论文部分内容阅读
目的：探讨卡络磺钠联合酚妥拉明治疗肺结核咯血的临床疗效。方法选取2013年1月~2014年1月我院收治的肺结核咯血患者60例，将患者随机分为观察组和对照组各30例，对照组给予酚妥拉明单一药物治疗，观察组在对照组基础上加用卡络磺钠治疗，比较两组患者的临床疗效。结果观察组的治疗总有效率为93.3%，明显高于对照组的76.7%，治疗有效率的组间差异有统计学意义(P0.05)，不具有统计学意义。结论临床上在治疗肺结核咯血时，可使用卡络磺钠和酚妥拉明联合疗法，有效改善患者的治疗效果，提高生活质量，值得推广使用。“,”Objective To investigate the clinical ef icacy of carbazochrome sodium sulfonate combined with phentolamine in treatment of hemoptysis of pulmonary tuberculosis. Methods 60 patients with hemoptysis of pulmonary tuberculosis from 2013 January to 2014 January in our hospital patients, the patients were randomly divided into observation group and control group with 30 cases in each group, the control group was given phentolamine single drug treatment, the observation group in the control group based on the use of carbazochrome sodium sulfonate treatment, the clinical ef icacy of two groups were compared. Results The treatment the total ef ective rate of observation group was 93.3%, significantly higher than 76.7%in the control group, the dif erence was statistical y significant treatment ef iciency between group ( 0.05), has no statistical significance. Conclusion Clinical y in the treatment of hemoptysis of pulmonary tuberculosis, can use carbazochrome sodium sulfonate and phentolamine combined therapy, ef ectively improve the patient's treatment ef ect, improve the quality of life, worthy of popularization.